- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
US Federal Court assures safety from Ranitidine, dismisses 2,500 lawsuits alleging cancer linkage with drug
The court ruling comes as a big win for pharmaceutical companies like Pfizer, Sanofi, GSK and Boehringer Ingelheim.
Washington: A United States Federal court dismissed the cancer linkage associated with Zantac (Ranitidine) assuring the safety of the use of Ranitidine for Indian patients.Almost 2,500 lawsuits alleging links between heartburn medication Zantac (Ranitidine) and cancer were dismissed by the court in US district of Florida.According to the judge, almost 2,500 lawsuits filed by plaintiffs in...
Washington: A United States Federal court dismissed the cancer linkage associated with Zantac (Ranitidine) assuring the safety of the use of Ranitidine for Indian patients.
Read also: Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751